 | • レポートコード：MRC2012B0885 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、非オピオイド鎮痛パッチの世界市場を広く調査・分析し、今後の市場展望をまとめております。非オピオイド鎮痛パッチの種類別市場規模（リドカインパッチ、ジクロフェナクパッチ、サリチル酸メチルパッチ、カプサイシンパッチ、ケトプロフェンパッチ、その他）、用途別市場規模（病院薬局、オンライン薬局、独立薬局、ドラッグストア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：GlaxoSmithKline Plc、Allergan、Mylan N.V.、Pfizer, Inc.、Endo International plc、Teikoku Seiyaku Co., Ltd.、IBSA Institut Biochimque SA、Acorda Therapeutics, Inc、Hisamitsu Pharmaceutical Co.,Inc、Teh Seng Pharmaceutical Mfg、 ・地域別グローバル市場分析 2015年-2020年 ・非オピオイド鎮痛パッチの北米市場（アメリカ、カナダ、メキシコ） ・非オピオイド鎮痛パッチのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・非オピオイド鎮痛パッチのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・非オピオイド鎮痛パッチの南米市場（ブラジル、アルゼンチン） ・非オピオイド鎮痛パッチの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：リドカインパッチ、ジクロフェナクパッチ、サリチル酸メチルパッチ、カプサイシンパッチ、ケトプロフェンパッチ、その他 ・用途別分析：病院薬局、オンライン薬局、独立薬局、ドラッグストア ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Non-opioid Analgesic Patch market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Non-opioid Analgesic Patch market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Non-opioid Analgesic Patch market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Non-opioid Analgesic Patch market has been segmented into:
Lidocaine Patches
Diclofenac Patches
Methyl Salicylate Patches
Capsaicin Patches
Ketoprofen Patches
Others
By Application, Non-opioid Analgesic Patch has been segmented into:
Hospital Pharmacies
Online Pharmacies
Independent Pharmacies & Drug Stores
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Non-opioid Analgesic Patch market presented in the report. This section sheds light on the sales growth of different regional and country-level Non-opioid Analgesic Patch markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Non-opioid Analgesic Patch market.
The report offers in-depth assessment of the growth and other aspects of the Non-opioid Analgesic Patch market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Non-opioid Analgesic Patch Market Share Analysis
Non-opioid Analgesic Patch competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Non-opioid Analgesic Patch sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Non-opioid Analgesic Patch sales, revenue and market share for each player covered in this report.
The major players covered in Non-opioid Analgesic Patch are:
GlaxoSmithKline Plc
Allergan
Mylan N.V.
Pfizer, Inc.
Endo International plc
Teikoku Seiyaku Co., Ltd.
IBSA Institut Biochimque SA
Acorda Therapeutics, Inc
Hisamitsu Pharmaceutical Co.,Inc
Teh Seng Pharmaceutical Mfg
Table of Contents
1 Non-opioid Analgesic Patch Market Overview
1.1 Product Overview and Scope of Non-opioid Analgesic Patch
1.2 Classification of Non-opioid Analgesic Patch by Type
1.2.1 Global Non-opioid Analgesic Patch Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Non-opioid Analgesic Patch Revenue Market Share by Type in 2019
1.2.3 Lidocaine Patches
1.2.4 Diclofenac Patches
1.2.5 Methyl Salicylate Patches
1.2.6 Capsaicin Patches
1.2.7 Ketoprofen Patches
1.2.8 Others
1.3 Global Non-opioid Analgesic Patch Market by Application
1.3.1 Overview: Global Non-opioid Analgesic Patch Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Independent Pharmacies & Drug Stores
1.4 Global Non-opioid Analgesic Patch Market by Regions
1.4.1 Global Non-opioid Analgesic Patch Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Non-opioid Analgesic Patch (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Non-opioid Analgesic Patch Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Non-opioid Analgesic Patch Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Non-opioid Analgesic Patch Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Non-opioid Analgesic Patch Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Non-opioid Analgesic Patch Status and Prospect (2015-2025)
2 Company Profiles
2.1 GlaxoSmithKline Plc
2.1.1 GlaxoSmithKline Plc Details
2.1.2 GlaxoSmithKline Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GlaxoSmithKline Plc SWOT Analysis
2.1.4 GlaxoSmithKline Plc Product and Services
2.1.5 GlaxoSmithKline Plc Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2018-2019)
2.2 Allergan
2.2.1 Allergan Details
2.2.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Allergan SWOT Analysis
2.2.4 Allergan Product and Services
2.2.5 Allergan Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2018-2019)
2.3 Mylan N.V.
2.3.1 Mylan N.V. Details
2.3.2 Mylan N.V. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Mylan N.V. SWOT Analysis
2.3.4 Mylan N.V. Product and Services
2.3.5 Mylan N.V. Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer, Inc.
2.4.1 Pfizer, Inc. Details
2.4.2 Pfizer, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer, Inc. SWOT Analysis
2.4.4 Pfizer, Inc. Product and Services
2.4.5 Pfizer, Inc. Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2018-2019)
2.5 Endo International plc
2.5.1 Endo International plc Details
2.5.2 Endo International plc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Endo International plc SWOT Analysis
2.5.4 Endo International plc Product and Services
2.5.5 Endo International plc Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2018-2019)
2.6 Teikoku Seiyaku Co., Ltd.
2.6.1 Teikoku Seiyaku Co., Ltd. Details
2.6.2 Teikoku Seiyaku Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Teikoku Seiyaku Co., Ltd. SWOT Analysis
2.6.4 Teikoku Seiyaku Co., Ltd. Product and Services
2.6.5 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2018-2019)
2.7 IBSA Institut Biochimque SA
2.7.1 IBSA Institut Biochimque SA Details
2.7.2 IBSA Institut Biochimque SA Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 IBSA Institut Biochimque SA SWOT Analysis
2.7.4 IBSA Institut Biochimque SA Product and Services
2.7.5 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2018-2019)
2.8 Acorda Therapeutics, Inc
2.8.1 Acorda Therapeutics, Inc Details
2.8.2 Acorda Therapeutics, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Acorda Therapeutics, Inc SWOT Analysis
2.8.4 Acorda Therapeutics, Inc Product and Services
2.8.5 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2018-2019)
2.9 Hisamitsu Pharmaceutical Co.,Inc
2.9.1 Hisamitsu Pharmaceutical Co.,Inc Details
2.9.2 Hisamitsu Pharmaceutical Co.,Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Hisamitsu Pharmaceutical Co.,Inc SWOT Analysis
2.9.4 Hisamitsu Pharmaceutical Co.,Inc Product and Services
2.9.5 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2018-2019)
2.10 Teh Seng Pharmaceutical Mfg
2.10.1 Teh Seng Pharmaceutical Mfg Details
2.10.2 Teh Seng Pharmaceutical Mfg Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Teh Seng Pharmaceutical Mfg SWOT Analysis
2.10.4 Teh Seng Pharmaceutical Mfg Product and Services
2.10.5 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Non-opioid Analgesic Patch Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Non-opioid Analgesic Patch Players Market Share
3.2.2 Top 10 Non-opioid Analgesic Patch Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Non-opioid Analgesic Patch Revenue and Market Share by Regions
4.2 North America Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
4.3 Europe Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
4.5 South America Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
5 North America Non-opioid Analgesic Patch Revenue by Countries
5.1 North America Non-opioid Analgesic Patch Revenue by Countries (2015-2020)
5.2 USA Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
5.3 Canada Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
5.4 Mexico Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
6 Europe Non-opioid Analgesic Patch Revenue by Countries
6.1 Europe Non-opioid Analgesic Patch Revenue by Countries (2015-2020)
6.2 Germany Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
6.3 UK Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
6.4 France Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
6.5 Russia Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
6.6 Italy Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Non-opioid Analgesic Patch Revenue by Countries
7.1 Asia-Pacific Non-opioid Analgesic Patch Revenue by Countries (2015-2020)
7.2 China Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
7.3 Japan Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
7.4 Korea Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
7.5 India Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
8 South America Non-opioid Analgesic Patch Revenue by Countries
8.1 South America Non-opioid Analgesic Patch Revenue by Countries (2015-2020)
8.2 Brazil Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
8.3 Argentina Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Non-opioid Analgesic Patch by Countries
9.1 Middle East & Africa Non-opioid Analgesic Patch Revenue by Countries (2015-2020)
9.2 Saudi Arabia Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
9.3 UAE Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
9.4 Egypt Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
9.5 South Africa Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Non-opioid Analgesic Patch Revenue and Market Share by Type (2015-2020)
10.2 Global Non-opioid Analgesic Patch Market Forecast by Type (2019-2024)
10.3 Lidocaine Patches Revenue Growth Rate (2015-2025)
10.4 Diclofenac Patches Revenue Growth Rate (2015-2025)
10.5 Methyl Salicylate Patches Revenue Growth Rate (2015-2025)
10.6 Capsaicin Patches Revenue Growth Rate (2015-2025)
10.7 Ketoprofen Patches Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Non-opioid Analgesic Patch Market Segment by Application
11.1 Global Non-opioid Analgesic Patch Revenue Market Share by Application (2015-2020)
11.2 Non-opioid Analgesic Patch Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2015-2020)
11.4 Online Pharmacies Revenue Growth (2015-2020)
11.5 Independent Pharmacies & Drug Stores Revenue Growth (2015-2020)
12 Global Non-opioid Analgesic Patch Market Size Forecast (2021-2025)
12.1 Global Non-opioid Analgesic Patch Market Size Forecast (2021-2025)
12.2 Global Non-opioid Analgesic Patch Market Forecast by Regions (2021-2025)
12.3 North America Non-opioid Analgesic Patch Revenue Market Forecast (2021-2025)
12.4 Europe Non-opioid Analgesic Patch Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Non-opioid Analgesic Patch Revenue Market Forecast (2021-2025)
12.6 South America Non-opioid Analgesic Patch Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Non-opioid Analgesic Patch Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Non-opioid Analgesic Patch Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Non-opioid Analgesic Patch by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Non-opioid Analgesic Patch Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Non-opioid Analgesic Patch Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. GlaxoSmithKline Plc Corporate Information, Location and Competitors
Table 6. GlaxoSmithKline Plc Non-opioid Analgesic Patch Major Business
Table 7. GlaxoSmithKline Plc Non-opioid Analgesic Patch Total Revenue (USD Million) (2017-2018)
Table 8. GlaxoSmithKline Plc SWOT Analysis
Table 9. GlaxoSmithKline Plc Non-opioid Analgesic Patch Product and Solutions
Table 10. GlaxoSmithKline Plc Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Allergan Corporate Information, Location and Competitors
Table 12. Allergan Non-opioid Analgesic Patch Major Business
Table 13. Allergan Non-opioid Analgesic Patch Total Revenue (USD Million) (2018-2019)
Table 14. Allergan SWOT Analysis
Table 15. Allergan Non-opioid Analgesic Patch Product and Solutions
Table 16. Allergan Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Mylan N.V. Corporate Information, Location and Competitors
Table 18. Mylan N.V. Non-opioid Analgesic Patch Major Business
Table 19. Mylan N.V. Non-opioid Analgesic Patch Total Revenue (USD Million) (2017-2018)
Table 20. Mylan N.V. SWOT Analysis
Table 21. Mylan N.V. Non-opioid Analgesic Patch Product and Solutions
Table 22. Mylan N.V. Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Pfizer, Inc. Corporate Information, Location and Competitors
Table 24. Pfizer, Inc. Non-opioid Analgesic Patch Major Business
Table 25. Pfizer, Inc. Non-opioid Analgesic Patch Total Revenue (USD Million) (2017-2018)
Table 26. Pfizer, Inc. SWOT Analysis
Table 27. Pfizer, Inc. Non-opioid Analgesic Patch Product and Solutions
Table 28. Pfizer, Inc. Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Endo International plc Corporate Information, Location and Competitors
Table 30. Endo International plc Non-opioid Analgesic Patch Major Business
Table 31. Endo International plc Non-opioid Analgesic Patch Total Revenue (USD Million) (2017-2018)
Table 32. Endo International plc SWOT Analysis
Table 33. Endo International plc Non-opioid Analgesic Patch Product and Solutions
Table 34. Endo International plc Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Teikoku Seiyaku Co., Ltd. Corporate Information, Location and Competitors
Table 36. Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Major Business
Table 37. Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Total Revenue (USD Million) (2017-2018)
Table 38. Teikoku Seiyaku Co., Ltd. SWOT Analysis
Table 39. Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Product and Solutions
Table 40. Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. IBSA Institut Biochimque SA Corporate Information, Location and Competitors
Table 42. IBSA Institut Biochimque SA Non-opioid Analgesic Patch Major Business
Table 43. IBSA Institut Biochimque SA Non-opioid Analgesic Patch Total Revenue (USD Million) (2017-2018)
Table 44. IBSA Institut Biochimque SA SWOT Analysis
Table 45. IBSA Institut Biochimque SA Non-opioid Analgesic Patch Product and Solutions
Table 46. IBSA Institut Biochimque SA Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Acorda Therapeutics, Inc Corporate Information, Location and Competitors
Table 48. Acorda Therapeutics, Inc Non-opioid Analgesic Patch Major Business
Table 49. Acorda Therapeutics, Inc Non-opioid Analgesic Patch Total Revenue (USD Million) (2017-2018)
Table 50. Acorda Therapeutics, Inc SWOT Analysis
Table 51. Acorda Therapeutics, Inc Non-opioid Analgesic Patch Product and Solutions
Table 52. Acorda Therapeutics, Inc Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Hisamitsu Pharmaceutical Co.,Inc Corporate Information, Location and Competitors
Table 54. Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Major Business
Table 55. Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Total Revenue (USD Million) (2017-2018)
Table 56. Hisamitsu Pharmaceutical Co.,Inc SWOT Analysis
Table 57. Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Product and Solutions
Table 58. Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Teh Seng Pharmaceutical Mfg Corporate Information, Location and Competitors
Table 60. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Major Business
Table 61. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Total Revenue (USD Million) (2017-2018)
Table 62. Teh Seng Pharmaceutical Mfg SWOT Analysis
Table 63. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product and Solutions
Table 64. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Non-opioid Analgesic Patch Revenue (Million USD) by Players (2015-2020)
Table 66. Global Non-opioid Analgesic Patch Revenue Share by Players (2015-2020)
Table 67. Global Non-opioid Analgesic Patch Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Non-opioid Analgesic Patch Revenue Market Share by Regions (2015-2020)
Table 69. North America Non-opioid Analgesic Patch Revenue by Countries (2015-2020)
Table 70. North America Non-opioid Analgesic Patch Revenue Market Share by Countries (2015-2020)
Table 71. Europe Non-opioid Analgesic Patch Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Non-opioid Analgesic Patch Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Non-opioid Analgesic Patch Revenue by Countries (2015-2020)
Table 74. South America Non-opioid Analgesic Patch Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Non-opioid Analgesic Patch Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Non-opioid Analgesic Patch Revenue Market Share by Countries (2015-2020)
Table 77. Global Non-opioid Analgesic Patch Revenue (Million USD) by Type (2015-2020)
Table 78. Global Non-opioid Analgesic Patch Revenue Share by Type (2015-2020)
Table 79. Global Non-opioid Analgesic Patch Revenue Forecast by Type (2021-2025)
Table 80. Global Non-opioid Analgesic Patch Revenue by Application (2015-2020)
Table 81. Global Non-opioid Analgesic Patch Revenue Share by Application (2015-2020)
Table 82. Global Non-opioid Analgesic Patch Revenue Forecast by Application (2021-2025)
Table 83. Global Non-opioid Analgesic Patch Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Non-opioid Analgesic Patch Picture
Figure 2. Global Non-opioid Analgesic Patch Revenue Market Share by Type in 2019
Figure 3. Lidocaine Patches Picture
Figure 4. Diclofenac Patches Picture
Figure 5. Methyl Salicylate Patches Picture
Figure 6. Capsaicin Patches Picture
Figure 7. Ketoprofen Patches Picture
Figure 8. Others Picture
Figure 9. Non-opioid Analgesic Patch Revenue Market Share by Application in 2019
Figure 10. Hospital Pharmacies Picture
Figure 11. Online Pharmacies Picture
Figure 12. Independent Pharmacies & Drug Stores Picture
Figure 13. Global Non-opioid Analgesic Patch Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Non-opioid Analgesic Patch Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Non-opioid Analgesic Patch Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Non-opioid Analgesic Patch Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Non-opioid Analgesic Patch Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Non-opioid Analgesic Patch Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Non-opioid Analgesic Patch Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Non-opioid Analgesic Patch Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Non-opioid Analgesic Patch Revenue Market Share in 2019
Figure 22. Global Top 10 Players Non-opioid Analgesic Patch Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Non-opioid Analgesic Patch Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Non-opioid Analgesic Patch Revenue Market Share by Regions (2015-2020)
Figure 26. Global Non-opioid Analgesic Patch Revenue Market Share by Regions in 2018
Figure 27. North America Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 28. Europe Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 30. South America Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 32. North America Non-opioid Analgesic Patch Revenue Market Share by Countries (2015-2020)
Figure 33. North America Non-opioid Analgesic Patch Revenue Market Share by Countries in 2019
Figure 34. USA Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 35. Canada Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 37. Europe Non-opioid Analgesic Patch Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Non-opioid Analgesic Patch Revenue Market Share by Countries in 2019
Figure 39. Germany Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 40. UK Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 41. France Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 42. Russia Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 43. Italy Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Non-opioid Analgesic Patch Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Non-opioid Analgesic Patch Revenue Market Share by Countries in 2019
Figure 46. China Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 47. Japan Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 48. Korea Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 49. India Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 51. South America Non-opioid Analgesic Patch Revenue Market Share by Countries (2015-2020)
Figure 52. South America Non-opioid Analgesic Patch Revenue Market Share by Countries in 2019
Figure 53. Brazil Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Non-opioid Analgesic Patch Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Non-opioid Analgesic Patch Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 58. UAE Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Non-opioid Analgesic Patch Revenue and Growth Rate (2015-2020)
Figure 61. Global Non-opioid Analgesic Patch Revenue Share by Type (2015-2020)
Figure 62. Global Non-opioid Analgesic Patch Revenue Share by Type in 2019
Figure 63. Global Non-opioid Analgesic Patch Market Share Forecast by Type (2021-2025)
Figure 64. Global Lidocaine Patches Revenue Growth Rate (2015-2020)
Figure 65. Global Diclofenac Patches Revenue Growth Rate (2015-2020)
Figure 66. Global Methyl Salicylate Patches Revenue Growth Rate (2015-2020)
Figure 67. Global Capsaicin Patches Revenue Growth Rate (2015-2020)
Figure 68. Global Ketoprofen Patches Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Non-opioid Analgesic Patch Revenue Share by Application (2015-2020)
Figure 71. Global Non-opioid Analgesic Patch Revenue Share by Application in 2019
Figure 72. Global Non-opioid Analgesic Patch Market Share Forecast by Application (2021-2025)
Figure 73. Global Hospital Pharmacies Revenue Growth Rate (2015-2020)
Figure 74. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 75. Global Independent Pharmacies & Drug Stores Revenue Growth Rate (2015-2020)
Figure 76. Global Non-opioid Analgesic Patch Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Non-opioid Analgesic Patch Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Non-opioid Analgesic Patch Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Non-opioid Analgesic Patch Revenue Market Forecast (2021-2025)
Figure 80. Europe Non-opioid Analgesic Patch Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Non-opioid Analgesic Patch Revenue Market Forecast (2021-2025)
Figure 82. South America Non-opioid Analgesic Patch Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Non-opioid Analgesic Patch Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
経皮的薬剤パッチの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Transdermal Drug Patches market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…- オピオイド誘発性便秘治療の世界市場（～2026年） There are multiple drugs in the pipeline for opioid induced constipation treatment. Upon approval, these drugs will face little competition in this market which is largely untapped. There have not been many stable choices in the pharmaceutical industry for opioid induced constipation treatment over …
- オピオイド誘発性便秘（OIC）治療の世界市場（～2026年） Market Analysis and Insights: Global Opioid-Induced Constipation (OIC) Treatment Market The global Opioid-Induced Constipation (OIC) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Opioid-Induced Constipation…
- カプサイシンパッチの世界市場（～2026年） Market Analysis and Insights: Global Capsaicin Patches Market The global Capsaicin Patches market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Capsaicin Patches Scope and Market Size Capsaicin Patches market is segmented b…
- オピオイド麻酔薬の世界市場（～2026年） Market Analysis and Insights: Global Opioid Anesthetics Market The global Opioid Anesthetics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Opioid Anesthetics Scope and Market Size Opioid Anesthetics market is segment…